Clinical Trial Update: Semaglutide Therapy for Alcohol Reduction (STAR) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating semaglutide for reducing alcohol use in individuals with Alcohol Use Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Addiction
• Alcohol Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Addiction, Alcohol Use Disorder | Phase 2 | Status: RECRUITING